2378114-72-6

Lanreotide (BIM 23014) acetate is a somatostatin analogue with antineoplastic activity. Lanreotide acetate can be used for the research of carcinoid syndrome[1][2].

[1] Ning S, et al. Lanreotide promotes apoptosis and is not radioprotective in GH3 cells.Endocr Relat Cancer.?2009 Sep;16(3):1045-55. DOI:10.1677/ERC-09-0003
[2] Florio T, et al. Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitro.Clin Endocrinol (Oxf).?2003 Jul;59(1):115-28. DOI:10.1046/j.1365-2265.2003.01811.x